Advertisement

Index by author

February 01, 2013; Volume 83,Issue 2

A

  1. Abali, Emine Ercikan

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  2. Abdul-Ridha, Alaa

    1. Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
      Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals and Arthur Christopoulos
      Molecular Pharmacology February 2013, 83 (2) 521-530; DOI: https://doi.org/10.1124/mol.112.083006

  3. Abood, Mary E.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  4. Abramowitz, Joel

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  5. AdeBisi Lawal, Rialnat

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  6. Ali, Juma A. M.

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

  7. Allison, Harriet C.

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

  8. Amraei, Mohammad

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  9. Anavi-Goffer, Sharon

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  10. Audet, Nicolas

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

B

  1. Baillie, Gemma L.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  2. Balboni, Gianfranco

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  3. Banerjee, Debabrata

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  4. Bertino, Joseph R.

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  5. Bhangoo, Sonia K.

    1. Kainate Receptor Signaling in Pain Pathways
      Sonia K. Bhangoo and Geoffrey T. Swanson
      Molecular Pharmacology February 2013, 83 (2) 307-315; DOI: https://doi.org/10.1124/mol.112.081398

  6. Birnbaumer, Lutz

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  7. Bolognini, Daniele

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  8. Boukamp, Petra

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  9. Bouvier, Michel

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  10. Brown, Steven J.

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  11. Bruno, Claudio

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  12. Büchele, Berthold

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

  13. Burgess, Karl

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

C

  1. Cahalan, Stuart M.

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  2. Camerino, Diana Conte

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  3. Canals, Meritxell

    1. Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
      Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals and Arthur Christopoulos
      Molecular Pharmacology February 2013, 83 (2) 521-530; DOI: https://doi.org/10.1124/mol.112.083006

  4. Carbonara, Roberta

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  5. Cavalluzzi, Maria Maddalena

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  6. Chakraborty, Goutam

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  7. Chisari, Mariangela

    1. Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
      Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
      Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794

  8. Choi, Kwan Yong

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  9. Christopoulos, Arthur

    1. Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
      Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals and Arthur Christopoulos
      Molecular Pharmacology February 2013, 83 (2) 521-530; DOI: https://doi.org/10.1124/mol.112.083006

  10. Cisar, Elizabeth A. George

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  11. Clevenger, Charles V.

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  12. Costanza, Teresa

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  13. Creek, Darren J.

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

D

  1. Dalvi, Pooja

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  2. De Koning, Harry P.

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

  3. Desaphy, Jean-François

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  4. Deutschmann, André

    1. Bisphenol A Inhibits Voltage-Activated Ca2+ Channels in Vitro: Mechanisms and Structural Requirements
      André Deutschmann, Michael Hans, Rainer Meyer, Hanns Häberlein and Dieter Swandulla
      Molecular Pharmacology February 2013, 83 (2) 501-511; DOI: https://doi.org/10.1124/mol.112.081372

E

  1. El Gaafary, Menna

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

F

  1. Field, Mark C.

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

  2. Flockerzi, Veit

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  3. Franchini, Carlo

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  4. Freichel, Marc

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

G

  1. Gonzalez-Cabrera, Pedro J.

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  2. Gottschall, Paul E.

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  3. Greulich-Bode, Karin M.

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  4. Guerrero, Miguel

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

H

  1. Häberlein, Hanns

    1. Bisphenol A Inhibits Voltage-Activated Ca2+ Channels in Vitro: Mechanisms and Structural Requirements
      André Deutschmann, Michael Hans, Rainer Meyer, Hanns Häberlein and Dieter Swandulla
      Molecular Pharmacology February 2013, 83 (2) 501-511; DOI: https://doi.org/10.1124/mol.112.081372

  2. Hampel, Sonja M.

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  3. Hans, Michael

    1. Bisphenol A Inhibits Voltage-Activated Ca2+ Channels in Vitro: Mechanisms and Structural Requirements
      André Deutschmann, Michael Hans, Rainer Meyer, Hanns Häberlein and Dieter Swandulla
      Molecular Pharmacology February 2013, 83 (2) 501-511; DOI: https://doi.org/10.1124/mol.112.081372

  4. Harper, Patricia A.

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  5. He, Hui-Qiong

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  6. Hébert, Terence E.

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  7. Hill, Kerstin

    1. Apomorphine Is a Bimodal Modulator of TRPA1 Channels
      Anja Schulze, Beatrice Oehler, Nicole Urban, Michael Schaefer and Kerstin Hill
      Molecular Pharmacology February 2013, 83 (2) 542-551; DOI: https://doi.org/10.1124/mol.112.081976

  8. Hogue, Mireille

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  9. Horswill, James G.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  10. Howell, Matthew D.

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  11. Hsieh, Yi-Ching

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

I

  1. Ikemura, Kenji

    1. MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
      Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
      Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844

  2. Ito, Kousei

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  3. Ito, Shinya

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  4. Iwamoto, Takuya

    1. MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
      Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
      Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844

J

  1. Johnson-Farley, Nadine

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

K

  1. Kerrigan, John E.

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  2. Kim, Do-Yeon

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  3. Kim, Kyong-Tai

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  4. Kim, Wanil

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  5. Kim, Ye Seul

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  6. Kovacevic, Zaklina

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  7. Kwon, Hyun-Sook

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

L

  1. Lane, J. Robert

    1. Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
      Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals and Arthur Christopoulos
      Molecular Pharmacology February 2013, 83 (2) 521-530; DOI: https://doi.org/10.1124/mol.112.083006

  2. Leaf, Nora B.

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  3. Leake, Brenda F.

    1. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
      Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
      Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513

  4. Lee, Kuo-Chieh

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  5. Lee, Kyung-Ha

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  6. Lentini, Giovanni

    1. Molecular Dissection of Lubeluzole Use–Dependent Block of Voltage-Gated Sodium Channels Discloses New Therapeutic Potentials
      Jean-François Desaphy, Roberta Carbonara, Teresa Costanza, Giovanni Lentini, Maria Maddalena Cavalluzzi, Claudio Bruno, Carlo Franchini and Diana Conte Camerino
      Molecular Pharmacology February 2013, 83 (2) 406-415; DOI: https://doi.org/10.1124/mol.112.080804

  7. Liao, Dan

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  8. Linsenbardt, Andrew J.

    1. Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
      Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
      Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794

  9. Lu, Xiaoli

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  10. Lunov, Oleg

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

  11. Lyu, Ha-Na

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

M

  1. Malhotra, Sanjay V.

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  2. Mäser, Pascal

    1. Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated Pyrimidines
      Juma A. M. Ali, Darren J. Creek, Karl Burgess, Harriet C. Allison, Mark C. Field, Pascal Mäser and Harry P. De Koning
      Molecular Pharmacology February 2013, 83 (2) 439-453; DOI: https://doi.org/10.1124/mol.112.082321

  3. Matthews, Jason

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  4. McAllister, Sean

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  5. Meiler, Jens

    1. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
      Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
      Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513

  6. Mennerick, Steven

    1. Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
      Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
      Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794

  7. Meyer, Rainer

    1. Bisphenol A Inhibits Voltage-Activated Ca2+ Channels in Vitro: Mechanisms and Structural Requirements
      André Deutschmann, Michael Hans, Rainer Meyer, Hanns Häberlein and Dieter Swandulla
      Molecular Pharmacology February 2013, 83 (2) 501-511; DOI: https://doi.org/10.1124/mol.112.081372

  8. Miyazaki, Saori

    1. MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
      Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
      Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844

  9. Mizutani, Hideki

    1. MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
      Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
      Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844

  10. Morad, Samy A. F.

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

N

  1. Nagi, Karim

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  2. Neidle, Stephen

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  3. Nguyen, Nhan

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

O

  1. Obuchi, Wataru

    1. Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
      Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
      Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083

  2. Oehler, Beatrice

    1. Apomorphine Is a Bimodal Modulator of TRPA1 Channels
      Anja Schulze, Beatrice Oehler, Nicole Urban, Michael Schaefer and Kerstin Hill
      Molecular Pharmacology February 2013, 83 (2) 542-551; DOI: https://doi.org/10.1124/mol.112.081976

  3. Ohmine, Ken

    1. Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
      Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
      Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083

  4. Ohtsuki, Sumio

    1. Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
      Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
      Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083

  5. Okuda, Masahiro

    1. MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
      Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
      Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844

P

  1. Pepe, Antonella

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  2. Pertwee, Roger G.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  3. Phelan, Kevin D.

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  4. Pineyro, Graciela

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

R

  1. Reggio, Patricia H.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  2. Reszka, Anthony P.

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

  3. Rhee, Sung W.

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  4. Richard-Lalonde, Melissa

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  5. Richardson, Des R.

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  6. Riddick, David S.

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  7. Roberts, Edward

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  8. Roden, Dan M.

    1. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
      Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
      Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513

  9. Rosen, Hugh

    1. Sphingosine 1-Phosphate Receptor 1 (S1P1) Upregulation and Amelioration of Experimental Autoimmune Encephalomyelitis by an S1P1 Antagonist
      Stuart M. Cahalan, Pedro J. Gonzalez-Cabrera, Nhan Nguyen, Miguel Guerrero, Elizabeth A. George Cisar, Nora B. Leaf, Steven J. Brown, Edward Roberts and Hugh Rosen
      Molecular Pharmacology February 2013, 83 (2) 316-321; DOI: https://doi.org/10.1124/mol.112.082958

  10. Ross, Douglas D.

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  11. Ross, Ruth A.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

S

  1. Sanders, Charles R.

    1. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
      Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
      Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513

  2. Santa, Tomofumi

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  3. Schaefer, Michael

    1. Apomorphine Is a Bimodal Modulator of TRPA1 Channels
      Anja Schulze, Beatrice Oehler, Nicole Urban, Michael Schaefer and Kerstin Hill
      Molecular Pharmacology February 2013, 83 (2) 542-551; DOI: https://doi.org/10.1124/mol.112.081976

  4. Schiller, Peter W.

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  5. Schmid, Maximilian

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

  6. Schulze, Anja

    1. Apomorphine Is a Bimodal Modulator of TRPA1 Channels
      Anja Schulze, Beatrice Oehler, Nicole Urban, Michael Schaefer and Kerstin Hill
      Molecular Pharmacology February 2013, 83 (2) 542-551; DOI: https://doi.org/10.1124/mol.112.081976

  7. Scotto, Kathleen

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  8. Sexton, Patrick M.

    1. Allosteric Modulation of a Chemogenetically Modified G Protein-Coupled Receptor
      Alaa Abdul-Ridha, J. Robert Lane, Patrick M. Sexton, Meritxell Canals and Arthur Christopoulos
      Molecular Pharmacology February 2013, 83 (2) 521-530; DOI: https://doi.org/10.1124/mol.112.083006

  9. Shu, Hong-Jin

    1. Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
      Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
      Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794

  10. Shwe, U Thaung

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  11. Siehl, Hans-Ullrich

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

  12. Simmet, Thomas

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

  13. Sleno, Rory

    1. Conformational Dynamics of Kir3.1/Kir3.2 Channel Activation Via δ-Opioid Receptors
      Melissa Richard-Lalonde, Karim Nagi, Nicolas Audet, Rory Sleno, Mohammad Amraei, Mireille Hogue, Gianfranco Balboni, Peter W. Schiller, Michel Bouvier, Terence E. Hébert and Graciela Pineyro
      Molecular Pharmacology February 2013, 83 (2) 416-428; DOI: https://doi.org/10.1124/mol.112.081950

  14. Smith, Jarrod A.

    1. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
      Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
      Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513

  15. Stephens, Gary J.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  16. Strange, Phillip G.

    1. CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
      Gemma L. Baillie, James G. Horswill, Sharon Anavi-Goffer, Patricia H. Reggio, Daniele Bolognini, Mary E. Abood, Sean McAllister, Phillip G. Strange, Gary J. Stephens, Roger G. Pertwee and Ruth A. Ross
      Molecular Pharmacology February 2013, 83 (2) 322-338; DOI: https://doi.org/10.1124/mol.112.080879

  17. Sun, Jing

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  18. Suzuki, Hiroshi

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  19. Swandulla, Dieter

    1. Bisphenol A Inhibits Voltage-Activated Ca2+ Channels in Vitro: Mechanisms and Structural Requirements
      André Deutschmann, Michael Hans, Rainer Meyer, Hanns Häberlein and Dieter Swandulla
      Molecular Pharmacology February 2013, 83 (2) 501-511; DOI: https://doi.org/10.1124/mol.112.081372

  20. Swanson, Geoffrey T.

    1. Kainate Receptor Signaling in Pain Pathways
      Sonia K. Bhangoo and Geoffrey T. Swanson
      Molecular Pharmacology February 2013, 83 (2) 307-315; DOI: https://doi.org/10.1124/mol.112.081398

  21. Syrovets, Tatiana

    1. A Novel Semisynthetic Inhibitor of the FRB Domain of Mammalian Target of Rapamycin Blocks Proliferation and Triggers Apoptosis in Chemoresistant Prostate Cancer Cells
      Samy A. F. Morad, Maximilian Schmid, Berthold Büchele, Hans-Ullrich Siehl, Menna El Gaafary, Oleg Lunov, Tatiana Syrovets and Thomas Simmet
      Molecular Pharmacology February 2013, 83 (2) 531-541; DOI: https://doi.org/10.1124/mol.112.081349

T

  1. Takada, Tappei

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  2. Tan, Jeng Kae

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  3. Tedeschi, Philip

    1. Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs
      Yi-Ching Hsieh, Philip Tedeschi, Rialnat AdeBisi Lawal, Debabrata Banerjee, Kathleen Scotto, John E. Kerrigan, Kuo-Chieh Lee, Nadine Johnson-Farley, Joseph R. Bertino and Emine Ercikan Abali
      Molecular Pharmacology February 2013, 83 (2) 339-353; DOI: https://doi.org/10.1124/mol.112.080218

  4. Terasaki, Tetsuya

    1. Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
      Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
      Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083

  5. Traynor, John R.

    1. Modulation of μ-Opioid Receptor Signaling by RGS19 in SH-SY5Y Cells
      Qin Wang and John R. Traynor
      Molecular Pharmacology February 2013, 83 (2) 512-520; DOI: https://doi.org/10.1124/mol.112.081992

U

  1. Uchida, Yasuo

    1. Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
      Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
      Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083

  2. Urban, Nicole

    1. Apomorphine Is a Bimodal Modulator of TRPA1 Channels
      Anja Schulze, Beatrice Oehler, Nicole Urban, Michael Schaefer and Kerstin Hill
      Molecular Pharmacology February 2013, 83 (2) 542-551; DOI: https://doi.org/10.1124/mol.112.081976

V

  1. Veith, Sebastian

    1. Mechanism of the Antiproliferative Activity of Some Naphthalene Diimide G-Quadruplex Ligands
      Sonja M. Hampel, Antonella Pepe, Karin M. Greulich-Bode, Sanjay V. Malhotra, Anthony P. Reszka, Sebastian Veith, Petra Boukamp and Stephen Neidle
      Molecular Pharmacology February 2013, 83 (2) 470-480; DOI: https://doi.org/10.1124/mol.112.081075

W

  1. Wang, Ming-Wei

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  2. Wang, Qin

    1. Modulation of μ-Opioid Receptor Signaling by RGS19 in SH-SY5Y Cells
      Qin Wang and John R. Traynor
      Molecular Pharmacology February 2013, 83 (2) 512-520; DOI: https://doi.org/10.1124/mol.112.081992

  3. Wang, Zhen-Guo

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  4. Wang, Zhong-Li

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  5. Wu, Alex Man Lai

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  6. Wu, Hong

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

Y

  1. Yamamoto, Hideaki

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  2. Yamamoto, Misato

    1. MicroRNA-145 Post-transcriptionally Regulates the Expression and Function of P-glycoprotein in Intestinal Epithelial Cells
      Kenji Ikemura, Misato Yamamoto, Saori Miyazaki, Hideki Mizutani, Takuya Iwamoto and Masahiro Okuda
      Molecular Pharmacology February 2013, 83 (2) 399-405; DOI: https://doi.org/10.1124/mol.112.081844

  3. Yamori, Takao

    1. Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics
      Wataru Obuchi, Sumio Ohtsuki, Yasuo Uchida, Ken Ohmine, Takao Yamori and Tetsuya Terasaki
      Molecular Pharmacology February 2013, 83 (2) 490-500; DOI: https://doi.org/10.1124/mol.112.081083

  4. Yang, Mingdong

    1. Induction of Multidrug Resistance Transporter ABCG2 by Prolactin in Human Breast Cancer Cells
      Alex Man Lai Wu, Pooja Dalvi, Xiaoli Lu, Mingdong Yang, David S. Riddick, Jason Matthews, Charles V. Clevenger, Douglas D. Ross, Patricia A. Harper and Shinya Ito
      Molecular Pharmacology February 2013, 83 (2) 377-388; DOI: https://doi.org/10.1124/mol.112.082362

  5. Yang, Tao

    1. An Allosteric Mechanism for Drug Block of the Human Cardiac Potassium Channel KCNQ1
      Tao Yang, Jarrod A. Smith, Brenda F. Leake, Charles R. Sanders, Jens Meiler and Dan M. Roden
      Molecular Pharmacology February 2013, 83 (2) 481-489; DOI: https://doi.org/10.1124/mol.112.081513

  6. Ye, Richard D.

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  7. Yoon, Ho Sup

    1. Obtusilactone B from Machilus Thunbergii Targets Barrier-to-Autointegration Factor to Treat Cancer
      Wanil Kim, Ha-Na Lyu, Hyun-Sook Kwon, Ye Seul Kim, Kyung-Ha Lee, Do-Yeon Kim, Goutam Chakraborty, Kwan Yong Choi, Ho Sup Yoon and Kyong-Tai Kim
      Molecular Pharmacology February 2013, 83 (2) 367-376; DOI: https://doi.org/10.1124/mol.112.082578

  8. Yoshikado, Takashi

    1. Ticlopidine, a Cholestatic Liver Injury-Inducible Drug, Causes Dysfunction of Bile Formation via Diminished Biliary Secretion of Phospholipids: Involvement of Biliary-Excreted Glutathione-Conjugated Ticlopidine Metabolites
      Takashi Yoshikado, Tappei Takada, Hideaki Yamamoto, Jeng Kae Tan, Kousei Ito, Tomofumi Santa and Hiroshi Suzuki
      Molecular Pharmacology February 2013, 83 (2) 552-562; DOI: https://doi.org/10.1124/mol.112.081752

  9. Yu, Andrew

    1. Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
      Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
      Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794

Z

  1. Zhang, Daohai

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  2. Zhao, Qian

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  3. Zheng, Fang

    1. Canonical Transient Receptor Channel 5 (TRPC5) and TRPC1/4 Contribute to Seizure and Excitotoxicity by Distinct Cellular Mechanisms
      Kevin D. Phelan, U Thaung Shwe, Joel Abramowitz, Hong Wu, Sung W. Rhee, Matthew D. Howell, Paul E. Gottschall, Marc Freichel, Veit Flockerzi, Lutz Birnbaumer and Fang Zheng
      Molecular Pharmacology February 2013, 83 (2) 429-438; DOI: https://doi.org/10.1124/mol.112.082271

  4. Zheng, Minhua

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  5. Zheng, Ying

    1. Targeting the Metastasis Suppressor, NDRG1, Using Novel Iron Chelators: Regulation of Stress Fiber-Mediated Tumor Cell Migration via Modulation of the ROCK1/pMLC2 Signaling Pathway
      Jing Sun, Daohai Zhang, Ying Zheng, Qian Zhao, Minhua Zheng, Zaklina Kovacevic and Des R. Richardson
      Molecular Pharmacology February 2013, 83 (2) 454-469; DOI: https://doi.org/10.1124/mol.112.083097

  6. Zhou, Hu-Chen

    1. Functional Characterization of Three Mouse Formyl Peptide Receptors
      Hui-Qiong He, Dan Liao, Zhen-Guo Wang, Zhong-Li Wang, Hu-Chen Zhou, Ming-Wei Wang and Richard D. Ye
      Molecular Pharmacology February 2013, 83 (2) 389-398; DOI: https://doi.org/10.1124/mol.112.081315

  7. Zorumski, Charles F.

    1. Noncompetitive, Voltage-Dependent NMDA Receptor Antagonism by Hydrophobic Anions
      Andrew J. Linsenbardt, Mariangela Chisari, Andrew Yu, Hong-Jin Shu, Charles F. Zorumski and Steven Mennerick
      Molecular Pharmacology February 2013, 83 (2) 354-366; DOI: https://doi.org/10.1124/mol.112.081794
Back to top

In this issue

Advertisement